Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients

被引：0
|
作者：
Galanis, Evanthia [1 ]
Hartmann, Lynn C. [1 ]
Cliby, William A. [1 ]
Zollman, Paula [1 ]
Peethambaram, Prema P. [1 ]
Long, Harry J. [1 ]
Kaur, Judith S. [1 ]
Sloan, Jeff A. [1 ]
Poland, Gregory A. [1 ]
Peng, Kah-Whye [1 ]
Russell, Stephen J. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.809
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
729
引用
收藏
页码：S281 / S281
页数：1
相关论文
共 50 条
  • [41] Phase II trial of intraperitoneal (IP) administration of catumaxomab (C) as consolidation therapy for patients (pts) with relapsed epithelial ovarian cancer (OC) in second or third complete remission: GEICO 1001 study.
    Romero, Ignacio
    Oaknin, Ana
    Angel Arranz, Jose
    Garcia-Martinez, Elena
    Herrero, Ana
    Casado, Antonio
    De Juan, Ana
    Guerra, Eva
    Hernando Polo, Susana
    Santaballa, Ana
    Poveda, Andres
    Gonzalez-Martin, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
    Pavlenko, M
    Roos, AK
    Lundqvist, A
    Palmborg, A
    Miller, AM
    Ozenci, V
    Bergman, B
    Egevad, L
    Hellström, M
    Kiessling, R
    Masucci, G
    Wersäll, P
    Nilsson, S
    Pisa, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 688 - 694
  • [43] A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer
    M Pavlenko
    A-K Roos
    A Lundqvist
    A Palmborg
    A M Miller
    V Ozenci
    B Bergman
    L Egevad
    M Hellström
    R Kiessling
    G Masucci
    P Wersäll
    S Nilsson
    P Pisa
    British Journal of Cancer, 2004, 91 : 688 - 694
  • [44] A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer.
    Li, Jing
    You, Zhi-yao
    Wu, Miao-fang
    Lin, Zhong-qiu
    Chen, Qing
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] PHASE-I TRIAL OF INTRAPERITONEAL RECOMBINANT INTERLEUKIN-2 LYMPHOKINE-ACTIVATED KILLER-CELLS IN PATIENTS WITH OVARIAN-CANCER
    STEWART, JA
    BELINSON, JL
    MOORE, AL
    DORIGHI, JA
    GRANT, BW
    HAUGH, LD
    ROBERTS, JD
    ALBERTINI, RJ
    BRANDA, RF
    CANCER RESEARCH, 1990, 50 (19) : 6302 - 6310
  • [46] Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer
    Rochlitz, C
    Figlin, R
    Squiban, P
    Salzberg, M
    Pless, M
    Herrmann, R
    Tartour, E
    Zhao, YX
    Bizouarne, N
    Baudin, M
    Acres, B
    JOURNAL OF GENE MEDICINE, 2003, 5 (08): : 690 - 699
  • [47] A Multicenter phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene
    Madhusudan, S
    Tamir, A
    Bates, N
    Flanagan, E
    Gore, ME
    Barton, DPJ
    Harper, P
    Seckl, M
    Thomas, H
    Lemoine, NR
    Charnock, M
    Habib, NA
    Lechler, R
    Nicholls, J
    Pignatelli, M
    Ganesan, TS
    CLINICAL CANCER RESEARCH, 2004, 10 (09) : 2986 - 2996
  • [48] A phase I trial of intratumoral administration of HF10 in patients with refractory superficial cancer: Immune correlates of virus injection.
    Gildener-Leapman, Neil
    Ferris, Robert L.
    Ohr, James
    Argiris, Athanassios
    Nemunaitis, John J.
    Senzer, Neil N.
    Bedell, Cindi
    Gross, Neil D.
    Vetto, John T.
    Tanaka, Maki
    Nishiyama, Yukihiro
    Ungerleider, Richard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer:: Effect of dose and EDTA coadministration on pharmacokinetics and toxicity
    Rosenblum, MG
    Verschraegen, CF
    Murray, JL
    Kudelka, AP
    Gano, J
    Cheung, L
    Kavanagh, JJ
    CLINICAL CANCER RESEARCH, 1999, 5 (05) : 953 - 961
  • [50] A phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer
    Wong, JYC
    Shibata, S
    Williams, LE
    Kwok, CS
    Liu, A
    Chu, DZ
    Yamauchi, DM
    Wilczynski, S
    Ikle, DN
    Wu, AM
    Yazaki, PJ
    Shively, JE
    Doroshow, JH
    Raubitschek, AA
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 5842 - 5852
12345